Utility of 90-Day Mortality vs 30-Day Mortality as a Quality Metric for Transcatheter and Surgical Aortic Valve Replacement Outcomes.

ABSTRACT:

Importance

Questions have recently arisen as to whether 30-day mortality is a reasonable metric for understanding institutional practice differences after transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR).

Objective

To examine the utility of 30-day vs 90-day mortality after TAVR and SAVR as a mortality quality metric.

Design, setting, and participants

This nationally representative, multicenter, cohort study analyzed data from Medicare beneficiaries undergoing TAVR and SAVR procedures from January 1, 2012, to December 31, 2015. Concomitant coronary artery bypass grafting and other heart valve or other major open-heart procedures were excluded. Hospitals that performed fewer than 50 TAVR or 70 SAVR procedures per year were exclu

SUBMITTER: Hirji S 

PROVIDER: S-EPMC6990722 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature